Increased Risk of Noninfluenza Respiratory Virus Infections Associated With Receipt of Inactivated Influenza Vaccine
2012; Oxford University Press; Volume: 54; Issue: 12 Linguagem: Inglês
10.1093/cid/cis307
ISSN1537-6591
AutoresBenjamin J. Cowling, Vicky J. Fang, Hiroshi Nishiura, Kwok‐Hung Chan, Sophia Ng, Dkm Ip, Susan S. Chiu, GM Leung, Malik Peiris,
Tópico(s)SARS-CoV-2 and COVID-19 Research
ResumoWe randomized 115 children to trivalent inactivated influenza vaccine (TIV) or placebo. Over the following 9 months, TIV recipients had an increased risk of virologically-confirmed non-influenza infections (relative risk: 4.40; 95% confidence interval: 1.31-14.8). Being protected against influenza, TIV recipients may lack temporary non-specific immunity that protected against other respiratory viruses.
Referência(s)